These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 38212958)

  • 21. TNF-α blockade suppresses pericystic inflammation following anthelmintic treatment in porcine neurocysticercosis.
    Mahanty S; Orrego MA; Cangalaya C; Adrianzen MP; Arroyo G; Calcina J; Gonzalez AE; García HH; Guerra-Giraldez C; Nash TE;
    PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006059. PubMed ID: 29190292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurocysticercosis: report of three cases and recommendations of treatment].
    Alvarez Rodríguez E; Torres-Gárate R; Gutiérrez Larráinzar A; Cabello J; Espinós Pérez D
    An Med Interna; 2004 Aug; 21(8):382-6. PubMed ID: 15373721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiparasitic treatment of neurocysticercosis - The effect of cyst destruction in seizure evolution.
    Garcia HH; Del Brutto OH;
    Epilepsy Behav; 2017 Nov; 76():158-162. PubMed ID: 28606690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A longitudinal analysis of albendazole treatment effect on neurocysticercosis cyst evolution using multistate models.
    Montgomery MA; Ramos M; Kelvin EA; Carpio A; Jaramillo A; Hauser WA; Zhang H
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):781-788. PubMed ID: 31433058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
    Fabbri J; Espinosa JP; Pensel PE; Medici SK; Gamboa GU; Benoit JP; Elissondo MC
    Acta Trop; 2020 Jan; 201():105215. PubMed ID: 31600525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Albendazole - Ivermectin combination decreases inflammation in experimental neurocysticercosis.
    da Silva Santana RC; Prudente TP; de Sousa Guerra CH; de Lima NF; de Souza Lino Junior R; Vinaud MC
    Exp Parasitol; 2023 Aug; 251():108568. PubMed ID: 37327965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case from India of neurocysticercosis responsive to albendazole treatment.
    Zardi EM; Petrarca V; Pozio E; Uwechie V; Tamburrini A; Laghi V
    Parasite; 2000 Mar; 7(1):54-6. PubMed ID: 10743650
    [No Abstract]   [Full Text] [Related]  

  • 29. Adhesion molecules, chemokines and matrix metallo-proteinases response after albendazole and albendazole plus steroid therapy in swine neurocysticercosis.
    Singh SK; Prasad KN; Singh AK; Gupta KK; Singh A; Tripathi M; Gupta RK
    Exp Parasitol; 2017 Nov; 182():1-8. PubMed ID: 28821422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of neurocysticercosis: a review].
    Nogales-Gaete J; Arriagada C; Salinas R
    Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia solium.
    Paredes A; de Campos Lourenço T; Marzal M; Rivera A; Dorny P; Mahanty S; Guerra-Giraldez C; García HH; Nash TE; Cass QB;
    Antimicrob Agents Chemother; 2013 Feb; 57(2):944-9. PubMed ID: 23229490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramedullary spinal neurocysticercosis treated successfully with medical therapy.
    Ahmed S; Paul SP
    J Egypt Soc Parasitol; 2014 Dec; 44(3):661-4. PubMed ID: 25643507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Partial reverse of the TCA cycle is enhanced in Taenia crassiceps experimental neurocysticercosis after in vivo treatment with anthelminthic drugs.
    de Almeida Leandro L; Fraga CM; de Souza Lino R; Vinaud MC
    Parasitol Res; 2014 Apr; 113(4):1313-7. PubMed ID: 24481905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
    Singh K; Saini AG; Khandelwal N; Singhi P
    J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anticysticercal treatment and seizures in neurocysticercosis.
    Singh G; Sander JW
    Lancet Neurol; 2004 Apr; 3(4):207-8. PubMed ID: 15039032
    [No Abstract]   [Full Text] [Related]  

  • 37. Etanercept to Control Inflammation in the Treatment of Complicated Neurocysticercosis.
    Nash TE; Ware JM; Coyle CM; Mahanty S
    Am J Trop Med Hyg; 2019 Mar; 100(3):609-616. PubMed ID: 30608049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of antiparasitic therapy for neurocysticercosis in rural Tanzania: a prospective cohort study.
    Stelzle D; Makasi C; Schmidt V; Trevisan C; Van Damme I; Ruether C; Dorny P; Magnussen P; Zulu G; Mwape KE; Bottieau E; Prazeres da Costa C; Prodjinotho UF; Carabin H; Jackson E; Fleury A; Gabriël S; Ngowi BJ; Winkler AS
    Infection; 2023 Aug; 51(4):1127-1139. PubMed ID: 36961623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
    Arroyo G; Bustos JA; Lescano AG; Gonzales I; Saavedra H; Rodriguez S; Pretell EJ; Bonato PS; Lanchote VL; Takayanagui OM; Horton J; Gonzalez AE; Gilman RH; Garcia HH;
    Clin Infect Dis; 2019 Nov; 69(11):1996-2002. PubMed ID: 30715265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural History of Treated Subarachnoid Neurocysticercosis.
    Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
    Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.